Physician profile
Tanya Rajdev
NPI 1225419856
$452.71
in general payments reported to CMS, 2019-2025
8 companies · $42.18 in 2025
The $42.18 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.62 · 2020: $85.39 · 2022: $84.96 · 2023: $180 · 2024: $47.14 · 2025: $42.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $205 · Education: $64.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $204.88 |
| Education | $64.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $213.05 | 2020-2025 | Invisalign System - Moderate, Invisalign, Itero Element 5d Plus |
| Henry Schein, INC. | $58.70 | 2022 | |
| Hu-Friedy Mfg. Co., LLC | $54.86 | 2023 | Ims |
| Dentsply Sirona INC | $35.73 | 2024 | Astra Tech Implant System |
| Gc America INC. | $29.43 | 2019-2025 | Equia, Gc Fuji Triage, G-Aenial |
| Ultradent Products INC | $25.67 | 2022-2024 | |
| Zimvie INC. | $20.31 | 2023 | |
| Colgate Oral Pharmaceuticals, INC. | $14.96 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanya Rajdev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.